SCHEMBL21149142

SCHEMBL21149142

c1ccc(-c2cc(-c3ccccc3)cc(-c3nc(-c4ccc5sc6ccccc6c5c4)nc(-c4cccc5sc6ccccc6c45)n3)c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM3 Q86V86 2/20 0.38
ALOX5 P09917 1/20 0.35
CYP1A2 P05177 1/20 0.34
GPR3 P46089 1/20 0.34
LIMK1 P53667 2/20 0.33
F9 P00740 1/20 0.33
ROCK1 Q13464 1/20 0.32
BRDT Q58F21 1/20 0.32
DUSP3 P51452 2/20 0.31
PTPN7 P35236 1/20 0.31
PTPN12 Q05209 1/20 0.31
PTPN22 Q9Y2R2 1/20 0.31
ADORA2A P29274 1/20 0.31
ADORA1 P30542 1/20 0.31
MAPT P10636 3/20 0.31
ALDH1A1 P00352 2/20 0.31
HPGD P15428 1/20 0.31
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
POLB P06746 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25944421 0.96 PIM3 (0.41) PIM3ALOX5CYP1A2GPR3LIMK1
SCHEMBL25950494 0.96 PIM3 (0.41) PIM3ALOX5CYP1A2GPR3LIMK1
SCHEMBL26080438 0.95 PIM3 (0.40) PIM3ALOX5CYP1A2GPR3LIMK1
SCHEMBL21149233 0.95 PIM3 (0.39) PIM3ALOX5CYP1A2GPR3LIMK1
SCHEMBL25730550 0.94 ALOX5 (0.37) PIM3ALOX5CYP1A2GPR3LIMK1
SCHEMBL26080448 0.93 PIM3 (0.39) PIM3ALOX5CYP1A2GPR3LIMK1
SCHEMBL22876157 0.93 PIM3 (0.40) PIM3ALOX5CYP1A2GPR3LIMK1
SCHEMBL25944660 0.93 PIM3 (0.38) PIM3ALOX5CYP1A2GPR3LIMK1
SCHEMBL19802678 0.93 PIM3 (0.40) PIM3ALOX5CYP1A2GPR3LIMK1
SCHEMBL19502369 0.93 PIM3 (0.36) PIM3ALOX5LIMK1F9ROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230329097-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO LTD (KR) 2023-10-12 US disclosed
US-20230329097-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO LTD (KR) 2023-10-12 US disclosed
US-20190214573-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2019-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190214573-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE OR10J3, OCIAD2, OCIAD1 PIM3 3857/4885ALOX5 306/4885CYP1A2 229/4885
US-20230329097-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE OR10J3, OCIAD2, OCIAD1 PIM3 3857/4885ALOX5 306/4885CYP1A2 229/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.